Page last updated: 2024-11-04

gatifloxacin and Asthma

gatifloxacin has been researched along with Asthma in 1 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, V1
Rizvi, W1
Dar, KA1
Bhargava, R1
Kumar, A1

Other Studies

1 other study available for gatifloxacin and Asthma

ArticleYear
Haemoptysis associated with gatifloxacin in a 27 year old male asthmatic--a case report.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:1

    Topics: Adult; Anti-Infective Agents; Asthma; Bronchitis; Fluoroquinolones; Gatifloxacin; Hemoptysis; Humans

2008